Hudson Executive Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
+$8.14M |
| 2 |
CTLP
Cantaloupe
CTLP
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
+$60.9M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.85M |
| 3 |
AtriCure
ATRC
|
+$2.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.79% |
| 2 | Industrials | 32.3% |
| 3 | Healthcare | 9.71% |
| 4 | Technology | 6.84% |
| 5 | Materials | 3.4% |
Similar funds
Hudson Executive Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Hudson Executive Capital held 12 positions worth $1.12B, down 15% from $1.32B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hudson Executive Capital withdrew a net $348M in Q4 2019, closing 4 positions and reducing 1 holding. Its most notable exit was CORINDUS VASCULAR ROBOTICS, INC, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 45% of assets, up from 37% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Hudson Executive Capital added an estimated $8.14M to Tivity Health, Inc. Common Stock.
- Hudson Executive Capital added most to Tivity Health, Inc. Common Stock in Q4 2019, an estimated $8.14M increase.
- Hudson Executive Capital's biggest Q4 2019 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $8.85M.
- Hudson Executive Capital fully exited CORINDUS VASCULAR ROBOTICS, INC in Q4 2019, selling an estimated $60.9M.
- Hudson Executive Capital's ten largest holdings make up 100% of its $1.12B portfolio in Q4 2019.
- Hudson Executive Capital opened 0 new positions and closed 4 in Q4 2019.
- Hudson Executive Capital's portfolio value fell 15% quarter-over-quarter to $1.12B.
Based on Hudson Executive Capital's 13F filing for Q4 2019, filed 14 Feb 2020.